CircMYOF acts as a miR-4739 sponge to promote progression and facilitate glycolysis via VEGFA/PI3K/AKT pathway in pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Zheng, Dandan [1 ]
Huang, Xianxian [2 ]
Peng, Juanfei [1 ]
Zhuang, Yanyan [1 ]
Li, Yuanhua [3 ]
Qu, Junchi [1 ]
Zhang, Shineng [1 ]
Huang, Fengting [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen, Peoples R China
[3] Sun Yat Sen Univ, Tungwah Hosp, Dongguan, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-026
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
    Liu, Xin
    Hu, Yi
    Li, Cairong
    Chen, Jiayu
    Liu, Xiaohong
    Shen, Yang
    Xu, Yangtao
    Chen, Wenliang
    Xu, Ximing
    CANCERS, 2023, 15 (06)
  • [42] MiR-19a-3p Promotes Aerobic Glycolysis in Ovarian Cancer Cells via IGFBP3/PI3K/AKT Pathway
    Du, Lijun
    Dou, Kaikai
    Zhang, Dan
    Xia, Huidong
    Liang, Nianhai
    Wang, Ningping
    Sun, Jianmin
    Bai, Ru
    FOLIA BIOLOGICA, 2023, 69 (5-6) : 163 - 172
  • [43] KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway
    Kai Wang
    Jinxiao Li
    Botao Zhou
    Metabolic Brain Disease, 2022, 37 : 489 - 499
  • [44] Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway
    Zhang, Xiao-Yu
    Mao, Ling
    GENE, 2021, 766
  • [45] NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway
    Zhang, Xinxin
    Wang, Hui
    Han, Yajuan
    Zhu, Mengqi
    Song, Zaozhi
    Zhan, Dankai
    Jia, Jianguang
    ONCOTARGETS AND THERAPY, 2020, 13 : 11315 - 11326
  • [46] PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors
    Tateishi, Kensuke
    Nakamura, Taishi
    Juratli, Tareq A.
    Williams, Erik A.
    Matsushita, Yuko
    Miyake, Shigeta
    Nishi, Mayuko
    Miller, Julie J.
    Tummala, Shilpa S.
    Fink, Alexandria L.
    Lelic, Nina
    Koerner, Mara V. A.
    Miyake, Yohei
    Sasame, Jo
    Fujimoto, Kenji
    Tanaka, Takahiro
    Minamimoto, Ryogo
    Matsunaga, Shigeo
    Mukaihara, Shigeo
    Shuto, Takashi
    Taguchi, Hiroki
    Udaka, Naoko
    Murata, Hidetoshi
    Ryo, Akihide
    Yamanaka, Shoji
    Curry, William T.
    Dias-Santagata, Dora
    Yamamoto, Tetsuya
    Ichimura, Koichi
    Batchelor, Tracy T.
    Chi, Andrew S.
    Iafrate, A. John
    Wakimoto, Hiroaki
    Cahill, Daniel P.
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4375 - 4387
  • [47] FNDC4 acts as an extracellular factor to promote the invasiveness of hepatocellular carcinoma partly via the PI3K/Akt signalling pathway
    Wang, Baolin
    Zheng, Bowen
    Lu, Yao
    Huang, Deng
    Liu, Jialong
    Song, Juxian
    Zheng, Shuguo
    CANCER MEDICINE, 2021, 10 (20): : 7242 - 7252
  • [48] NLRC5 Activates the PI3K/AKT Pathway to Facilitate the Invasion and Metastasis of Lung Adenocarcinoma Cells
    Wen, Linchun
    Xu, Lu
    Cai, Beibei
    Liu, Zihao
    Wang, Lixue
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (11): : 5945 - 5954
  • [49] Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR-9 pathway
    Bing, Weidong
    Pang, Xinyan
    Qu, Qingxi
    Bai, Xiao
    Yang, Wenwen
    Bi, Yanwen
    Bi, Xiaolu
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (05) : 949 - 961
  • [50] MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway
    Qiang Zhang
    Yunzhen Wang
    Medical Oncology, 39
12345